RT Journal Article
ID 0e25b3eb2d50474b
A1 Rai, Mahendra K.
A1 Gaikwad, Swapnil
A1 Nagaonkar, Dipali
A1 dos Santos, Carolina Alves
T1 Current Advances in the Antimicrobial Potential of Species of Genus Ganoderma (Higher Basidiomycetes) against Human Pathogenic Microorganisms (Review)
JF International Journal of Medicinal Mushrooms
JO IJM
YR 2015
FD 2016-01-07
VO 17
IS 10
SP 921
OP 932
K1 medicinal mushrooms
K1 antimicrobial bioactive compounds
K1 Ganoderma spp.
K1 metal nanoparticles
AB Ganoderma spp. are very important therapeutic mushrooms and have been used traditionally for 4000 years in the treatment of various human disorders. Different species of Ganoderma possess bioactive compounds, which have already demonstrated antiviral, antibacterial, and antifungal activities. Various bioactive compounds such as triterpenoids, colossolactones, and polysaccharides, which are responsible for the antimicrobial potential of the genus, are discussed here in detail. Some Ganoderma spp. have been reported to be potential agents for the synthesis of metal nanoparticles. These nanoparticles have demonstrated antimicrobial activity and also are reviewed herein. The main aim of this review is to discuss the possible use of Ganoderma extracts and their active principles in antimicrobial therapy.
PB Begell House
LK https://www.dl.begellhouse.com/journals/708ae68d64b17c52,2fb21a9c4fd053ea,0e25b3eb2d50474b.html